-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N+76Zm36e8QqdHPtHpjcV7h8VYGt7IkCALAQNaw1NrJMguxOQBXspM6lBA7MBRhU HFLDAlE90cRUgOTtlkCa4g== 0001237899-09-000014.txt : 20090429 0001237899-09-000014.hdr.sgml : 20090429 20090429114148 ACCESSION NUMBER: 0001237899-09-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090427 FILED AS OF DATE: 20090429 DATE AS OF CHANGE: 20090429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTS WILLIAM CENTRAL INDEX KEY: 0001226687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 09777901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-04-27 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226687 ROBERTS WILLIAM 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Regul Devel & Clin Safety Common Stock 2009-04-27 4 M 0 15160 6.5 A 82116 D Common Stock 2009-04-27 4 S 0 15160 12.74 D 66956 D Common Stock 1200 I by trust for daught Common Stock 3492 I By 401(k) Plan Common Stock 8106 I by Spouse Common Stock 1200 I by trust for daught Incentive Stock Option (right to buy) 6.5 2009-04-27 4 M 0 15160 D 2009-05-03 Common Stock 15160 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 15,160 shares of Company stock on April 27, 2009 at prices ranging from$12.50 to $12.97. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on April 27, 2009 at each separate price. The stock option becomes exercisable in five equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**William G. Roberts 2009-04-29 -----END PRIVACY-ENHANCED MESSAGE-----